The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Adma Biologics Inc (NASDAQ: ADMA) closed at $17.70 in the last session, down -4.99% from day before closing price of $18.63. In other words, the price has decreased by -$4.99 from its previous closing price. On the day, 2.94 million shares were traded. ADMA stock price reached its highest trading level at $18.97 during the session, while it also had its lowest trading level at $17.315.
Ratios:
We take a closer look at ADMA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 48.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.70. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 22 ’24 when Tade Brad L. sold 15,000 shares for $21.15 per share. The transaction valued at 317,250 led to the insider holds 199,433 shares of the business.
Grossman Adam S sold 48,967 shares of ADMA for $1,033,204 on Nov 22 ’24. The President and CEO now owns 1,989,007 shares after completing the transaction at $21.10 per share. On Nov 22 ’24, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 48,967 shares for $21.30 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4184103168 and an Enterprise Value of 4208784384. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 64.06, and their Forward P/E ratio for the next fiscal year is 24.33. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.20. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.93 while its Price-to-Book (P/B) ratio in mrq is 18.04. Its current Enterprise Value per Revenue stands at 10.994 whereas that against EBITDA is 33.431.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $4.06. The 50-Day Moving Average of the stock is -6.21%, while the 200-Day Moving Average is calculated to be 31.41%.
Shares Statistics:
According to the various share statistics, ADMA traded on average about 4.69M shares per day over the past 3-months and 2140240 shares per day over the past 10 days. A total of 236.38M shares are outstanding, with a floating share count of 228.48M. Insiders hold about 3.35% of the company’s shares, while institutions hold 88.43% stake in the company. Shares short for ADMA as of 1732838400 were 12906077 with a Short Ratio of 2.75, compared to 1730332800 on 15198480. Therefore, it implies a Short% of Shares Outstanding of 12906077 and a Short% of Float of 5.6199998.
